Back

Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease / Acute Coronary Syndromes Treatment ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Satoshi Yasuda

Tohoku University, Sendai (Japan)

3 More presentations in this session

Presentation thumbnail
Real-world comparison of intracoronary imaging and fractional flow reserve measurements on outcomes of semi-urgent and elective percutaneous coronary intervention in a multi-ethnic asian population
Doctor R. Soh (Singapore, SG)
Abstract Slides
Presentation thumbnail
The impact of diabetes mellitus on improvement of resting rate pressure product in patients with refractory angina undergone external counter pulsation
Doctor A. Yasmin (Denpasar, ID)
Abstract Slides
Presentation thumbnail
Investigating factors associated with the prevalence of IHD among uncontrolled diabetic patients
Mrs S. Shaharuddin (Selangor, MY)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease / Acute Coronary Syndromes

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources